Kaisa Health Group Holdings Ltd. Reports HK$88.5 Million Revenue and HK$24.3 Million Net Loss for Six Months Ended June 2024
Kaisa Health Group Holdings Ltd. reported interim results for the six months ended June 30, 2025, with total revenue of HK$69.6 million, down from HK$88.5 million in 2024. The dental segment generated HK$66.4 million, a decrease from HK$85.9 million, while the health care segment increased to HK$3.1 million. The net loss narrowed to HK$9.3 million from HK$24.3 million. The total comprehensive income was HK$4.4 million, compared to a comprehensive expense of HK$34.2 million in the previous period. No significant updates on business operations were disclosed.
Kaisa Health Group Holdings Ltd. reported its interim results for the six months ended 30 June 2025. The group recorded total revenue of HK$69.6 million, compared to HK$88.5 million for the same period in 2024. The dental business segment contributed HK$66.4 million in revenue, down from HK$85.9 million a year earlier, while the health care business segment generated HK$3.1 million, compared to HK$2.6 million for the prior period. The group reported a net loss of HK$9.3 million for the period, narrowing from a net loss of HK$24.3 million for the same period last year. Loss before income tax was HK$9.3 million, compared to HK$22.6 million in the prior year. Segment results for the dental business showed a segment loss before depreciation and amortisation of HK$12.0 million, compared to a segment profit before depreciation and amortisation of HK$1.9 million in the previous period. The health care business reported a segment profit before depreciation and amortisation of HK$2.5 million, up from HK$1.6 million. The total comprehensive income for the period was HK$4.4 million, compared to a total comprehensive expense of HK$34.2 million in the previous period, reflecting exchange differences arising on translation of foreign operations. No significant updates about business or operations were disclosed in the interim report. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaisa Health Group Holdings Ltd. published the original content used to generate this news brief on September 25, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
